Bempegaldesleukin Plus Nivolumab for Untreated Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results
J. Clin. Oncol 2023 Aug 31;[EPub Ahead of Print], A Diab, H Gogas, S Sandhu, GV Long, PA Ascierto, J Larkin, M Sznol, F Franke, TE Ciuleanu, C Pereira, E Muñoz Couselo, F Bronzon Damian, M Schenker, A Perfetti, C Lebbe, G Quéreux, F Meier, BD Curti, C Rojas, Y Arriaga, H Yang, M Zhou, S Ravimohan, P Statkevich, MA Tagliaferri, NI KhushalaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.